NCT03750721已完成不适用
Staphylococcal Acute Post-Operative Prosthetic Joint Infection Treated With 'DAIR' (Debridement and Implant Retention) And Impact Of Rifampin: A Retrospective Cohort Study In France
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 79
- 试验地点
- 1
- 主要终点
- description of the use of rifampicin : rate of use
研究概览
简要总结
S. aureus and coagulase-negative staphylococci are the most frequent bacteria responsible for PJI (prosthetic joint infection). The aim of this study is to describe the use of rifampicin.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients having had acute PJI (i.e. <1 month following the implantation), DAIR with exchange of removal components) due to S. aureus and coagulase-negative staphylococci (2011-2016)
排除标准
- 未提供
结局指标
主要结局
description of the use of rifampicin : rate of use
时间窗: Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)
the aim is to determine how the use of rifampin influence the prognosis in staphylococcal acute post-operative prosthetic joint infection treated with DAIR
次要结局
- rate of failure for treatment using rifampin(Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption))
- rate of adverse event with rifampin(Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption))
研究者
Eugénie MABRUT
Clinical Research Assistant
Hospices Civils de Lyon
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Evaluation of the Tolerance of Ceftaroline and Ceftobiprole in the Management of BJI / PJIBone and Joint InfectionAntibiotic ReactionNCT04409769Hospices Civils de Lyon22
已完成
不适用
Clinical Relevance of Intracellular Staphylococci in BOne and Joint InfectionsBone and Joint InfectionStaphylococcusNCT04625478Hospices Civils de Lyon50
已完成
不适用
Pristinamycin in the Treatment of MSSA Bone and Joint InfectionMethicillin Susceptible Staphylococcus Aureus (MSSA) InfectionBone and Joint InfectionNCT03177343Hospices Civils de Lyon102
已完成
不适用
Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous AdministrationTeicoplanin-based Antimicrobial TherapyStaphylococcus AureusBone and Joint InfectionNCT03177369Hospices Civils de Lyon60
Enrolling By Invitation
4 期
Probiotics in the Prevention of Recurrent Prosthetic Joint Infection of the Hip and KneeProsthetic-joint InfectionDysbiosisNCT06636669Boston Medical Center152